GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unionkorea Pharm Co Ltd (XKRX:080720) » Definitions » Deferred Policy Acquisition Costs

Unionkorea Pharm Co (XKRX:080720) Deferred Policy Acquisition Costs


View and export this data going back to 2018. Start your Free Trial

What is Unionkorea Pharm Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Unionkorea Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, 417, Samwhan-HIPEX A Tower B/D 240, Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 13493
Unionkorea Pharm Co Ltd is a pharmaceutical company. The company is engaged in the development, manufacturing and marketing of brain metabolism enhancer, prescription drugs, Anti-inflammatory analgesics, and skeletal muscle relaxants.